APRI (Aprinoia Therapeutics) OCF Yield %: 0.00 (As of Jun. 25, 2026)


What is Aprinoia Therapeutics OCF Yield %?

Aprinoia Therapeutics APRI OCF Yield % is 0.00 as of Jun. 25, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Aprinoia Therapeutics's Trailing 12-Month Cash Flow from Operations is $-14.74 Mil, and Market Cap is $0.00 Mil. Therefore, Aprinoia Therapeutics's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Aprinoia Therapeutics's OCF Yield % or its related term are showing as below:


APRI's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -8.46
* Ranked among companies with meaningful OCF Yield % only.

Aprinoia Therapeutics's OCF Margin % for the quarter that ended in Dec. 2023 was %.

Aprinoia Therapeutics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Aprinoia Therapeutics OCF Yield % Related Terms

Aprinoia Therapeutics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics OCF Yield % Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
OCF Yield %
0.00 0.00 0.00

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
OCF Yield % 0.00 0.00 0.00 0.00 0.00

Aprinoia Therapeutics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Aprinoia Therapeutics's OCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-14.739 / 0
=N/A%

Aprinoia Therapeutics's annualized OCF Yield % for the quarter that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-9.288 * 2 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Aprinoia Therapeutics (APRI) has a OCF Yield % of 0.00 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' OCF Yield % too high?
Aprinoia Therapeutics' current OCF Yield % is 0.00.
How does Aprinoia Therapeutics' OCF Yield % compare to ?
Aprinoia Therapeutics' OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current OCF Yield % is 0.00 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.